Streetbeat News

Analyst Ratings

AVNW

JMP Securities analyst Erik Suppiger has reiterated a 'Market Outperform' rating on Aviat Networks (NASDAQ:AVNW) and maintained a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:54 pm

COR

Mizuho analyst Omotayo Okusanya maintains a Neutral rating on Cencora (NYSE:COR) and raises the price target from $192 to $224 as of 2 February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:53 pm

PCOR

JMP Securities analyst Joe Goodwin has maintained a Market Outperform rating on Procore Technologies (PCOR) and increased the price target from $69 to $81.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:52 pm

NTNX

JMP Securities analyst Erik Suppiger has maintained a Market Outperform rating on Nutanix (NTNX) and increased the price target from $50 to $70.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:50 pm

DOCU

Deep-pocketed investors have shown a bearish trend towards DocuSign (NASDAQ:DOCU), with options trading data revealing a significant move. Benzinga's tracking highlighted 13 extraordinary options activities, with a sentiment split of 46% bullish and 53% bearish. The targeted price range for DOCU over the last 3 months is between $50.0 and $65.0. The current market status shows DOCU's price down by -1.41% at $57.3, with a neutral RSI. Analyst ratings vary, with a consensus target price of $66.0 but differing views from RBC Capital, JMP Securities, and Morgan Stanley.

Portfolio Pulse from Benzinga Insights

February 05, 2024 | 5:45 pm

KVYO

Goldman Sachs analyst Gabriela Borges upgraded Klaviyo Inc (NYSE:KVYO) from Neutral to Buy, maintaining a price target of $36. Despite a 22% underperformance over the past three months, Borges sees 2024 as a pivotal year with three main catalysts: overdone concerns around email spam filtering changes, potential market share gains, and upside to estimates from company-specific drivers and stable consumer spending. Shares of Klaviyo rose 4.8% in premarket trading.

Portfolio Pulse from Priya Nigam

February 05, 2024 | 5:42 pm

FDMT

BMO Capital analyst Kostas Biliouris maintains an Outperform rating on 4D Molecular Therapeutics (NASDAQ:FDMT) and raises the price target from $50 to $70.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:41 pm

CI

Cigna Group (NYSE:CI) shares rose after reporting Q4 results, with analysts upgrading ratings and raising price targets following the company's 2024 guidance. The guidance suggests Evernorth revenues will exceed consensus estimates by $10 billion. Analysts highlight Cigna's strong earnings growth visibility, supported by share repurchases and solid operating conditions. Cigna is named a 'Top Pick for 2024' by Mizuho Securities, citing solid EPS visibility and reduced legislative risk.

Portfolio Pulse from Priya Nigam

February 05, 2024 | 5:39 pm

EVBG

Canaccord Genuity analyst Michael Walkley downgraded Everbridge (NASDAQ:EVBG) from Buy to Hold and set a price target of $28.6.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:30 pm

SKM

Nomura analyst Angela Hong downgrades SK Telecom Co (NYSE:SKM) from Neutral to Reduce, indicating a negative outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:28 pm